TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31122111

Group type: EXPERIMENTAL
Intervention: Functional Circuit Training plus 10-week home program (FCT-PA)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Functional Circuit Training plus Health Education (FCT-HE)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Flexibility and Toning plus Health Education (FT-HE)
Number of subjects: 111
Study: 29714870

Group type: EXPERIMENTAL
Intervention: Left lateral position for 15 minutes before turning to supine position
Number of subjects: 60

Group type: COMPARATOR
Intervention: Supine position immediately after spinal anesthesia
Number of subjects: 60
Study: 25828745

Group type: EXPERIMENTAL
Intervention: Hypomethylating agents (HMA) therapy (median of 12 courses, range 1-24)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Hypomethylating agents (HMA) therapy (12 cycles or more)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Hypomethylating agents (HMA) therapy (fewer than 12 cycles)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Patients with poor-risk cytogenetics
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Patients without poor-risk cytogenetics
Number of subjects: 16
Study: 23417031

Group type: EXPERIMENTAL
Intervention: Valsartan (up to 160mg daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No valsartan (control)
Number of subjects: 0
Study: 21036583

Group type: EXPERIMENTAL
Intervention: Olive leaf extract (500 mg twice daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Captopril (12.5 mg twice daily, titrated to 25 mg if necessary)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Olive leaf extract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 0
Study: 19812260

Group type: EXPERIMENTAL
Intervention: MenACWY-CRM
Number of subjects: 1359

Group type: COMPARATOR
Intervention: Menactra
Number of subjects: 1359
Study: 18080399

Group type: EXPERIMENTAL
Intervention: Maraviroc combined with optimized background therapy (OBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maraviroc
Number of subjects: 0
Study: 15535413

Group type: EXPERIMENTAL
Intervention: Self-reported medication adherence
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Undetectable PI concentrations
Number of subjects: 131

Group type: COMPARATOR
Intervention: Frequent HIV RNA measurement group
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Detectable PI concentrations
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Baseline HIV RNA level
Number of subjects: 131
Study: 11442282

Group type: EXPERIMENTAL
Intervention: 100 mg extended phenytoin sodium capsules (Lot 1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 100 mg extended phenytoin sodium capsules (Lot 2)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 100 mg extended phenytoin sodium capsules (Lot 3)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 100 mg extended phenytoin sodium capsules (all lots)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 100 mg extended phenytoin sodium capsules (females)
Number of subjects: 24
Study: 9505274

Group type: EXPERIMENTAL
Intervention: Preterm infant formula from discharge to 6 months (group A)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Term formula from discharge to 6 months (group B)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Preterm formula (discharge to term) and term formula (term to 6 months) (group C)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Comparison of nutrient intake
Number of subjects: 3
Study: 8312411

Group type: EXPERIMENTAL
Intervention: Amino acid dialysis
Number of subjects: 7

Group type: COMPARATOR
Intervention: Dextrose dialysis
Number of subjects: 7
Study: 2841053

Group type: EXPERIMENTAL
Intervention: atenolol 50-100 mg/day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: enalapril 5-20 mg/day
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: atenolol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: enalapril
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: furosemide
Number of subjects: 20
Study: 31400077

Group type: EXPERIMENTAL
Intervention: Biological causal explanation
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Psychosocial causal explanation
Number of subjects: 229

Group type: COMPARATOR
Intervention: Non-causal control
Number of subjects: 229
Study: 29896844

Group type: EXPERIMENTAL
Intervention: Supervised physical training (two weekly sessions for 26 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no physical training)
Number of subjects: 60
Study: 28253045

Group type: EXPERIMENTAL
Intervention: Preoperative physical activity counseling for 6 weeks, encouraging daily walking at moderate intensity in bouts ≥ 10 minutes during morning hours
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Participants whose longest MVPA bouts occurred during morning hours (n = 11)
Number of subjects: 33
Study: 25923718

Group type: EXPERIMENTAL
Intervention: Low-frequency (0.2 Hz) repetitive transcranial magnetic stimulation (rTMS) over the anterior cingulate cortex (ACC)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Low-frequency (0.2 Hz) repetitive transcranial magnetic stimulation (rTMS) over the dorsal premotor cortex (dPM)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Low-frequency (0.2 Hz) repetitive transcranial magnetic stimulation (rTMS) over the primary motor cortex (MC)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Low-frequency (0.2 Hz) repetitive transcranial magnetic stimulation (rTMS) over the supplementary motor area (SMA)
Number of subjects: 8
Study: 22936619

Group type: EXPERIMENTAL
Intervention: TAXUS or Express bare metal stents
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Angiographic thrombus (+)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Angiographic thrombus (-)
Number of subjects: 43
Study: 22204173

Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation (TENS) therapy
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Constant mode of TENS therapy
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Burst mode of TENS therapy
Number of subjects: 31
Study: 19759166

Group type: EXPERIMENTAL
Intervention: 120 mg soy hypocotyl aglycone isoflavones plus calcium and vitamin D
Number of subjects: 403

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 403
Study: 16463415

Group type: EXPERIMENTAL
Intervention: Exercise therapy in a warm, waist-high pool (3 weekly sessions for 12 weeks)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Exercise therapy in a warm, waist-high pool
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 34
Study: 14760123

Group type: EXPERIMENTAL
Intervention: ASCT-rituximab
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional chemotherapy
Number of subjects: 20
Study: 11281054

Group type: EXPERIMENTAL
Intervention: Low-dose mutant tissue-type plasminogen activator (mt-PA), monteplase, 80 x 10(4) U bolus
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Low-dose mutant tissue-type plasminogen activator (mt-PA), monteplase
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group (no administration of mt-PA)
Number of subjects: 164
Study: 9548608

Group type: EXPERIMENTAL
Intervention: Balloon stopflow infusion combined with micro‐embolization
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Stopflow infusion of the celiac axis combined with microspheres
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intra-arterial infusion with tumor adjusted concentrations
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Overall pain response
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Quality of life
Number of subjects: 100
Study: 7923966

Group type: EXPERIMENTAL
Intervention: Oral 1,25(OH)2D3
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Intraperitoneal (IP) 1,25(OH)2D3
Number of subjects: 7
Study: 3187415

Group type: EXPERIMENTAL
Intervention: Flexible fiberoptic cystourethroscopy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional cystourethroscopy
Number of subjects: 30
Study: 31517597

Group type: EXPERIMENTAL
Intervention: Treatment group (received free radon and air nicotine test kits, report back, telephone support, and $600 voucher for mitigation)
Number of subjects: 515

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Treatment group (with high radon levels at baseline)
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 515
Study: 27918762

Group type: EXPERIMENTAL
Intervention: 8-week alternating treatment schedule of pazopanib 800 mg/d and everolimus 10 mg/d (rotating arm)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Continuous pazopanib 800 mg/d (control arm)
Number of subjects: 101
Study: 25753207

Group type: EXPERIMENTAL
Intervention: 1 g aspirin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 23286420

Group type: EXPERIMENTAL
Intervention: Low Glycemic Index (LGI) meal
Number of subjects: 10

Group type: COMPARATOR
Intervention: High Glycemic Index (HGI) meal
Number of subjects: 10
Study: 21713395

Group type: EXPERIMENTAL
Intervention: 30 Gy/3 fractions/15 days (arm A)
Number of subjects: 71

Group type: COMPARATOR
Intervention: 40 Gy/4 fractions/22 days (arm B)
Number of subjects: 71
Study: 19452582

Group type: EXPERIMENTAL
Intervention: Ropivacaine infusion at port sites
Number of subjects: 72

Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 72
Study: 16442896

Group type: EXPERIMENTAL
Intervention: Orbufiban
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 15250181

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 11167672

Group type: EXPERIMENTAL
Intervention: Nasal drops (800 microg doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nasal spray (800 microg doses)
Number of subjects: 0
Study: 9051855

Group type: EXPERIMENTAL
Intervention: Serum substance P levels in rheumatoid arthritis patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study: 8385022

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (13C labelled) at doses between 12.5 and 100 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (13C labelled)
Number of subjects: 10
Study: 3708186

Group type: EXPERIMENTAL
Intervention: Doxapram (0.5 mg X kg‐1 lean body mass bolus followed by 1 mg X min‐1 infusion)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 31239638

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 µg/kg in 20 mL of normal saline
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 0.5 µg/kg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 100
Study: 29730208

Group type: EXPERIMENTAL
Intervention: Cartilage fragments
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control (no cartilage fragments)
Number of subjects: 116
Study: 25355940

Group type: EXPERIMENTAL
Intervention: PCV13
Number of subjects: 1866

Group type: COMPARATOR
Intervention: PCV7
Number of subjects: 1866
Study: 24424627

Group type: EXPERIMENTAL
Intervention: Image-guided radiotherapy (IGRT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional radiotherapy (RT) - Group 1 (single photon field, posterior-anterior direction)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional radiotherapy (RT) - Group 2 (single photon field, posterior-anterior direction)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional radiotherapy (RT) - Group 3 (three-dimensional conformal treatment plan)
Number of subjects: 30
Study: 22244035

Group type: EXPERIMENTAL
Intervention: Swimming training
Number of subjects: 43

Group type: COMPARATOR
Intervention: Attention time controls
Number of subjects: 43
Study: 19535697

Group type: EXPERIMENTAL
Intervention: Licorice gargle (0.5 g licorice in water)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Water (control group)
Number of subjects: 40
Study: 17211432

Group type: EXPERIMENTAL
Intervention: Vaccinated donor (DV+ group)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Unvaccinated donor (DV- group)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: High antibody concentration donors
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Low-specific antibody concentration donors
Number of subjects: 111
Study: 16420082

Group type: EXPERIMENTAL
Intervention: Escitalopram (10-20 mg/day)
Number of subjects: 526
Study: 12002756

Group type: EXPERIMENTAL
Intervention: Filgrastim-mobilised PBPCs (n = 37)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Bone marrow transplant (ABMT) (n = 35)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Overall survival (OS)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Progression-free survival
Number of subjects: 72
Study: 10098104

Group type: EXPERIMENTAL
Intervention: Constrained Longitudinal Splines (CLS) semiparametric method
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard nonlinear weighted least squares approach (reference value)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: NONMEM POSTHOC method using parametric and CLS methods
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Monte Carlo simulation approach
Number of subjects: 90
Study: 7618480

Group type: EXPERIMENTAL
Intervention: Static handgrip exercise at 30% of maximal voluntary contraction
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: One-leg knee extension exercise at 30% of maximal voluntary contraction
Number of subjects: 8
Study: 1514339

Group type: EXPERIMENTAL
Intervention: Propofol 2.5 mg/kg
Number of subjects: 76

Group type: COMPARATOR
Intervention: Thiopentone 4 mg/kg
Number of subjects: 76
Study: 6391136

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 1436

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1436
Study: 31061074

Group type: EXPERIMENTAL
Intervention: Health TAPESTRY
Number of subjects: 312

Group type: COMPARATOR
Intervention: Control
Number of subjects: 312
Study: 29386413

Group type: EXPERIMENTAL
Intervention: Vitamin D therapy, 50000 IU intramuscularly (IM) monthly for 6 months
Number of subjects: 85

Group type: COMPARATOR
Intervention: Distilled water IM (control group)
Number of subjects: 85
Study: 27941696

Group type: EXPERIMENTAL
Intervention: Environmentally-friendly (EF) wallpaper
Number of subjects: 31

Group type: COMPARATOR
Intervention: Polyvinyl chloride (PVC) wallpaper
Number of subjects: 31
Study: 24906244

Group type: EXPERIMENTAL
Intervention: ALVAC-HIV and AIDSVAX B/E prime-boost regimen (vaccine)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 22812438

Group type: EXPERIMENTAL
Intervention: Slow Maxillary Expansion (SME)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Rapid Maxillary Expansion (RME)
Number of subjects: 26
Study: 20693796

Group type: EXPERIMENTAL
Intervention: Chlorhexidine-ethanol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Povidone-iodine
Number of subjects: 0
Study: 17918152

Group type: COMPARATOR
Intervention: Former smokers
Number of subjects: 103081

Group type: COMPARATOR
Intervention: Current smokers
Number of subjects: 103081

Group type: COMPARATOR
Intervention: Women who smoked for more than 20 years
Number of subjects: 103081

Group type: COMPARATOR
Intervention: Smoking intensity (pack-years) and duration (number of years)
Number of subjects: 103081
Study: 15733266

Group type: EXPERIMENTAL
Intervention: Group counseling
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Individual counseling
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Decision aid
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 577
Study: 12877416

Group type: COMPARATOR
Intervention: 10% carbamide peroxide for two weeks (Group A - negative control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sodium perborate mixed with 3% hydrogen peroxide (modified walking bleach technique) for four weeks (Group B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 10% carbamide peroxide for two weeks (Group C)
Number of subjects: 60
Study: 10516692

Group type: EXPERIMENTAL
Intervention: Filgrastim (5 microg/kg/day) starting on day 0
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Filgrastim (5 microg/kg/day) starting on day +5
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Filgrastim (5 microg/kg/day) starting on day +10
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Filgrastim starting on day +10
Number of subjects: 69

Group type: COMPARATOR
Intervention: All groups (day 0, day +5, day +10)
Number of subjects: 69
Study: 7516191

Group type: EXPERIMENTAL
Intervention: GM-CSF (two daily subcutaneous injections of 54 or 108 micrograms)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 3
Study: 2684990

Group type: EXPERIMENTAL
Intervention: Broad arm sling
Number of subjects: 60

Group type: COMPARATOR
Intervention: Reduction and fixation with a coracoclavicular screw
Number of subjects: 60
Study: 794520

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Cephalexin
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control (no antibacterial agent)
Number of subjects: 210
Study: 31640647

Group type: EXPERIMENTAL
Intervention: Implementation of district mental health care plan (MHCP)
Number of subjects: 1983
Study: 28615271

Group type: EXPERIMENTAL
Intervention: Supervised moderate-to-high intensity aerobic exercise (1 hour, 3 times weekly for 16 weeks)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis
Number of subjects: 200
Study: 26194272

Group type: EXPERIMENTAL
Intervention: CSII + sitagliptin
Number of subjects: 217

Group type: COMPARATOR
Intervention: CSII
Number of subjects: 217
Study: 23916805

Group type: EXPERIMENTAL
Intervention: On-pump coronary artery bypass graft surgery
Number of subjects: 2203

Group type: COMPARATOR
Intervention: Off-pump coronary artery bypass graft surgery
Number of subjects: 2203

Group type: EXPERIMENTAL
Intervention: Off-pump to on-pump conversions
Number of subjects: 2203

Group type: COMPARATOR
Intervention: On-pump and off-pump comparison
Number of subjects: 2203
Study: 21438987

Group type: EXPERIMENTAL
Intervention: Ural (sodium bicarbonate)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo (glucose)
Number of subjects: 300
Study: 18313122

Group type: EXPERIMENTAL
Intervention: Urinary Symptom Profile (USP) questionnaire
Number of subjects: 328
Study: 16710711

Group type: EXPERIMENTAL
Intervention: Vitamin E (300 mg/day) plus vitamin C (500 mg/day) for 12 weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (non-exposed staff)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Technical anaesthesiology staff before antioxidant treatment
Number of subjects: 17
Study: 12566215

Group type: EXPERIMENTAL
Intervention: Face-to-face counselling
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Telephone counselling
Number of subjects: 205

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 205
Study: 11055032

Group type: EXPERIMENTAL
Intervention: Preschool education (intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random allocation (intervention)
Number of subjects: 0
Study: 8836715

Group type: EXPERIMENTAL
Intervention: Extracorporeal piezoelectric lithotripsy (ESWL, n = 79)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Intracorporeal electrohydraulic lithotripsy (EHL, n = 46)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Combined treatment including ESWL, EHL, and intracorporeal laser lithotripsy
Number of subjects: 125

Group type: COMPARATOR
Intervention: Both groups (ESWL and EHL)
Number of subjects: 125
Study: 8268363

Group type: EXPERIMENTAL
Intervention: Norfloxacin (400 mg, orally, twice daily for 3 days)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo (orally, twice daily for 3 days)
Number of subjects: 106
Study: 3519327

Group type: EXPERIMENTAL
Intervention: Electromyographic biofeedback, relaxation-response training, and pain behavior management
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Relaxation-response training and pain behavior management
Number of subjects: 18

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 18
Study: 29902597

Group type: EXPERIMENTAL
Intervention: Translaminar approach (key-hole laminotomy)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Interlaminar approach
Number of subjects: 48
Study: 27564310

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting bioresorbable scaffold (Absorb)
Number of subjects: 501

Group type: COMPARATOR
Intervention: Everolimus-eluting metallic stent (XIENCE)
Number of subjects: 501
Study: 24472112

Group type: EXPERIMENTAL
Intervention: PA/MD model (physician assistants functioning as hospitalists alongside medical doctors)
Number of subjects: 460

Group type: COMPARATOR
Intervention: MD model (traditional model with medical doctors as hospitalists)
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: PA/MD model
Number of subjects: 460
Study: 22420584

Group type: EXPERIMENTAL
Intervention: Enteral methadone (MG)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 68
Study: 20434108

Group type: EXPERIMENTAL
Intervention: Airtraq laryngoscope
Number of subjects: 63

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Both laryngoscopes
Number of subjects: 63
Study: 18382267

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15756571

Group type: EXPERIMENTAL
Intervention: Prednisolone 1%
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Rimexolone 1%
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 0.5%
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 45
Study: 12004637

Group type: EXPERIMENTAL
Intervention: Chart reminder intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no chart reminder)
Number of subjects: 0
Study: 10738351

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 392

Group type: COMPARATOR
Intervention: PTCA (Percutaneous Transluminal Coronary Angioplasty)
Number of subjects: 392

Group type: COMPARATOR
Intervention: PTCA
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Surgery and PTCA
Number of subjects: 392